Tech Company Financing Transactions
Capstan Therapeutics Funding Round
Capstan Therapeutics, based in San Diego, received $175 million from RA Capital Management, Alexandria Venture Investments and Bristol Myers Squibb.
Transaction Overview
Company Name
Announced On
3/21/2024
Transaction Type
Venture Equity
Amount
$175,000,000
Round
Series B
Investors
RA Capital Management (Lead Investor)
Proceeds Purpose
The company intends to use the funds to advance CPTX2309, its lead in vivo chimeric antigen receptor T cell (CAR-T) candidate, to early clinical proof-of-concept in autoimmune disorders, and to further develop Capstan's tLNP pipeline.
Company Information
Company Status
Private & Independent
Industry
Healthcare Services
Mailing Address
9880 Campus Point Dr 220
San Diego, CA 92121
USA
San Diego, CA 92121
USA
Phone
Undisclosed
Website
Email Address
Overview
Capstan's mission is to multiply the therapeutic possibilities for patients by developing targeted in vivo RNA-based therapies. Our core platform technology pertains to proprietary targeted lipid nanoparticles (tLNPs) that are composed of LNPs conjugated with a recombinant protein binder, such as a monoclonal antibody, and are designed to deliver payloads, including mRNA or gene editing tools, capable of reprograming specific cell types in vivo.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Laura Shawver
Chief Financial Officer
Justin Thacker
Chief Medical Officer
Ramin Farzaneh-Far
Chief Scientific Officer
Adrian Bot
Chief Technical Officer
Priya Karmali
Vice President
Gregor Adams
Vice President
David Diamond
VP - Bus. Development
Miguel Arcinas
VP - General Counsel
Jeffrey Pepe
VP - Product Management
Michael Rosenzweig
VP - R & D
Haig Aghajanian
VP - Regulatory Affairs
Michelle Mazzoni
Browse more venture capital transactions:
Prev: 3/21/2024: Profluent venture capital transaction
Next: 3/21/2024: Cemvision venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on tech company VC transactions. VC investment data records on this site come from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs